Andrew Waddington: 3 mid-cap stocks to watch

Andrew Waddington: 3 mid-cap stocks to watch. The Australian share market is battling headwinds from the resources sector, due both to lower iron ore and oil prices. In such an environment an active, stock-specific strategy can thrive as opportunities emerge among the more unloved, cyclical sectors. Many of these opportunities lie in the mid-cap market, which remains divided between a band of expensive growth stocks and others offering far more attractive valuations. ResMed is a great example of a business in the sweet spot of its life cycle and we've held it as one of the larger positions in our MidCap Fund since inception for a number of reasons. Health Care stocks are generally more defensive in nature and this firm has demonstrated consistent cash flow, controlled working capital and more importantly an appetite for delivering share buy backs and dividends. Going forward we like its strong core business and solid pipeline of new products to treat other medical issues. Which other stocks do we favour? Click here for more (VIEW LINK)